Results 191 to 200 of about 3,006,184 (303)

SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2. [PDF]

open access: yesEMBO Mol Med
Cho HJ   +19 more
europepmc   +1 more source

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.

open access: yesBlood, 2006
A. Pardanani   +13 more
semanticscholar   +1 more source

In vitro cell growth in neonates with Down's syndrome and transient myeloproliferative disorder [PDF]

open access: bronze, 1981
JF Denegri   +4 more
openalex   +1 more source

292 Morgana Haploinsufficiency Induces a Myeloproliferative Disorder Like-chronic Myeloid Leukemia

open access: bronze, 2012
Augusta Di Savino   +9 more
openalex   +1 more source

Four Cases of Myeloproliferative Disorders Associated With Down Syndrome: Distinguishing ML-DS From TAM-DS: Distinguishing TAM-DS and ML-DS: Report of 4 Cases. [PDF]

open access: yesCase Rep Hematol
Boumeghar K   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy